AmpliPhi Biosciences (APHB) Misses Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
AmpliPhi Biosciences Reports First Quarter 2018 Financial Results and Business Highlights
May 15, 2018 4:02 PM EDTAnnounced positive topline results for the initial seven patients treated with AB-SA01 or AB-PA01 under ongoing expanded access program and presented detailed results for the first patient at a medical conference Signed collaborative agreements with the U.S. Department of Veterans Affairs and the Westmead Hospital in Sydney Completed two financings for combined gross proceeds of approximately $7.0 million Targeting meeting with the FDA in mid-2018 Webcast/conference call begins at 4:30 p.m. EDT/1:30 p.m. PDT today
SAN... More
